Skip to main content
Caplight Logo









Detechgene

Detechgene

Private
CologneHealthcare & Life Scienceshttps://detechgene.de

Last Round

Seed

Aug 25, 2025

Total Funding Raised

$6.28M

Company Overview

Detechgene is a biotechnology company that develops a mobile rapid molecular diagnostic platform for the detection of viral, bacterial, and fungal pathogens.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care testingPOCTmolecular diagnosticsrapid PCRPCRpathogen detectiondiagnostic hardwareisothermal amplificationrazor-and-blademedical devicelab-on-a-chipdecentralized diagnosticsdiagnostic consumablesbiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Detechgene Comparables

Compare Detechgene with similar companies based on industry and business-model similarity.

Detechgene comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Anavasi Diagnostics
87%
GeneSys Bio
85%
BIOPIX-T
83%

Detechgene Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 25, 2025
GrantJun 2, 2024

Key People

Founding team and executive leadership

Robin Bayer

CTO And Co-Founder

Founding Team

Reza Esmaillie

CEO And Co-Founder

Founding Team

Detechgene Investors

Notable investors and investment history

Detechgene investors
InvestorRounds
Meerkat HoldingSeed
neoteq venturesSeed
NRW.BankSeed, Pre Seed
Aquarius Invest GmbHSeed
Campus CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    DIAGURIN project launched within the gesünder.in.nrw initiative.

  • Nov 9, 2025

    Received founding category recognition for innovative PCR rapid test.

Detechgene Filings

Explore SEC and related filing metadata, where available.

Detechgene filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Detechgene's valuation, stock price, and market status.

Is Detechgene a public or private company?

Detechgene is a private company.

What is the current stock price of Detechgene?

Detechgene is a private company with no public stock price. No recent secondary market data is available.

How much is Detechgene worth (valuation)?

Valuation information for Detechgene is not publicly available.

Can I buy Detechgene stock?

Detechgene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Detechgene's last funding round?

Detechgene's most recent funding round was Seed on August 27, 2025.

Who are the main investors in Detechgene?

Key investors in Detechgene include neoteq ventures.

Will Detechgene IPO soon?

No public IPO plans have been announced for Detechgene.

How can I track Detechgene secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Detechgene's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCologne
Employee Range13
Year Founded2022
Last FundingAug 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?